enzalutamide
Clinical- Indications
- Cancer
Company intelligence / Profile preview
Nanoform
Helsinki, Uusimaa, Finlandnanoform.com ↗
- Ownership
- Public · NANOFH
- Employees
- ~143
- Development stage
- Commercial
01
Overview
Nanoform provides enabling nanonization technologies that improve solubility, bioavailability, and formulation performance of both small molecules and biologics. Its CESS® technology has demonstrated the ability to create nanoparticles as small as 10 nm for small molecules, with biological nanoforming reaching down to 50 nm while retaining protein activity. The company’s technologies have enabled promising preclinical results in partnered programs, such as tumor eradication in rodent models of glioblastoma multiforme with TargTex[7]. First human pilot PK studies using their technology are targeted for H2 2025[6].
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologicNanoparticleHydrogel-based drug delivery therapy
- Industry
- Drug Discovery Services
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
TargTex – enabling hydrogel-based nanoparticle therapy for glioblastoma multiformeDozens of undisclosed pharma/biotech clients globally.
04
Financials
- Market cap
- $68.3M
- Total revenue
- $78.3M
Beyond the preview
Go deeper on Nanoform.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanoform.